Secondary Metabolites from Food-Derived Yeasts Inhibit Virulence of <named-content content-type="genus-species">Candida albicans</named-content>
ABSTRACT A sparse number of available antifungal drugs, therapeutic side effects, and drug resistance are major challenges in current antifungal therapy to treat Candida albicans-associated infections. Here, we describe two food-derived yeasts, Saccharomyces cerevisiae and Issatchenkia occidentalis,...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
American Society for Microbiology
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/c0108ff4dc6241c7a072179e6360ff8f |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|